Carotuximab (Anti-Endoglin / CD105)
Carotuximab (Anti-Endoglin / CD105) (A2514-GRP)
Products
Description
Carotuximab (Anti-Endoglin / CD105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions. MW: 145.5 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2514 |
| Target | CD markers |